Cargando…

Effect of Half-dose and Standard-dose Conjugated Equine Estrogens Combined with Natural Progesterone or Dydrogesterone on Components of Metabolic Syndrome in Healthy Postmenopausal Women: A Randomized Controlled Trial

BACKGROUND: Menopausal hormone therapy (MHT) has been proven to have beneficial effects on several components of metabolic syndrome. However, the effects vary according to different regimens, dosages, and duration of MHT. The aim of the study was to evaluate the effect of standard-dose 0.625 mg conj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Wei, Deng, Yan, Wang, Yan-Fang, Sun, Ai-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146781/ https://www.ncbi.nlm.nih.gov/pubmed/27900987 http://dx.doi.org/10.4103/0366-6999.194646

Ejemplares similares

Effects of Estradiol/Micronized Progesterone vs. Conjugated Equine Estrogens/Medroxyprogesterone Acetate on Breast Cancer Gene Expression in Healthy Postmenopausal Women
por: Lalitkumar, Parameswaran Grace Luther, et al.
Publicado: (2023)

Conjugated equine estrogen used in postmenopausal women associated with a higher risk of stroke than estradiol
por: Chang, Wei-Chuan, et al.
Publicado: (2021)

The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis
por: Lee, Hee Joong, et al.
Publicado: (2017)

The Addition of Dydrogesterone after Frozen Embryo Transfer in Hormonal Substituted Cycles with Low Progesterone Levels
por: Metello, Jose, et al.
Publicado: (2022)

The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT‐FET cycles
por: Toriumi, Rena, et al.
Publicado: (2023)

Dydrogesterone in the treatment of endometriosis: evidence mapping and meta-analysis
por: Peng, Chao, et al.
Publicado: (2021)

Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?
por: Netter, Antoine, et al.
Publicado: (2019)

Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial
por: Griesinger, Georg, et al.
Publicado: (2018)

A Comparison of Oral Dydrogesterone with Vaginal Progesterone for Luteal-Phase Support in In vitro Fertilization: A Randomized Controlled Trial
por: Naghshineh, Elham, et al.
Publicado: (2023)

Serum estradiol level according to dose and formulation of oral estrogens in postmenopausal women
por: Kim, Soo-Min, et al.
Publicado: (2021)

Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial
por: Salehpour, Saghar, et al.
Publicado: (2013)

Supplementary dydrogesterone is beneficial as luteal phase support in artificial frozen-thawed embryo transfer cycles compared to micronized progesterone alone
por: Vidal, Angela, et al.
Publicado: (2023)

Effects of low-dose tamoxifen on breast cancer biomarkers Ki-67, estrogen and progesterone receptors
por: de Sousa, Juarez Antônio, et al.
Publicado: (2006)

Analysis of low-dose estrogen on callus BMD as measured by pQCT in postmenopausal women
por: Jäckle, K., et al.
Publicado: (2020)

Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis
por: Griesinger, Georg, et al.
Publicado: (2020)

A randomised control trial on oral dydrogesterone versus micronized vaginal progesterone pessary for luteal phase support in in vitro fertilization cycles
por: Ikechebelu, Joseph Ifeanyichukwu, et al.
Publicado: (2023)

Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis
por: Barbosa, Marina Wanderley Paes, et al.
Publicado: (2018)

A systematic review of dydrogesterone for the treatment of threatened miscarriage
por: Carp, Howard
Publicado: (2012)

The Future of Luteal Phase Support in ART and the Role of Dydrogesterone
por: Drakopoulos, Panagiotis, et al.
Publicado: (2021)

The value of high dose tamoxifen in postmenopausal breast cancer patients progressing on standard doses: a pilot study.
por: Watkins, S. M.
Publicado: (1988)

Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot study
por: Simon, Virginie, et al.
Publicado: (2022)

Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women
por: Liu, Hongzhong, et al.
Publicado: (2020)

The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women
por: Williams, Andrew E, et al.
Publicado: (2002)

Dydrogesterone as an Option in the Medical Treatment of Endometriosis: A Brief Comment
por: Carvalho, Bruno Ramalho de
Publicado: (2022)

A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization
por: Tournaye, Herman, et al.
Publicado: (2017)

Estrogen deficiency is associated with hippocampal morphological remodeling of early postmenopausal mice
por: Yan, Yan, et al.
Publicado: (2017)

Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps: A comparison between benign and malignant polyps in postmenopausal patients
por: ANTUNES, ARMANDO, et al.
Publicado: (2014)

Estrogen and Progesterone Receptor Immunoexpression in Fallopian Tubes among Postmenopausal Women Based on Time since the Last Menstrual Period
por: Brodowska, Agnieszka, et al.
Publicado: (2021)

Estrogen, Progesterone and Epithelial Ovarian Cancer
por: Ho, Shuk-Mei
Publicado: (2003)

The Impact of Progesterone and Estrogen on the Tooth Mobility
por: Peruga, Małgorzata, et al.
Publicado: (2023)

INTERACTION OF ESTROGEN AND PROGESTERONE IN CHICK OVIDUCT DEVELOPMENT : II. Effects of Estrogen and Progesterone on Tubular Gland Cell Function
por: Oka, Takami, et al.
Publicado: (1969)

Tramadol half life is dose dependent in overdose
por: Khosrojerdi, Hamid, et al.
Publicado: (2015)

Suppressed estrogen supply via extra-ovarian progesterone receptor membrane component 1 in menopause
por: Lee, Sang R., et al.
Publicado: (2021)

FRI683 Every Dose Counts: Response To Half The Recommended Dose Of Romosozumab
por: Ramchandani, Bhanvi Prakash, et al.
Publicado: (2023)

Evaluation of radiation dose reduction in head CT using the half-dose method
por: Nakai, Yoshitomo, et al.
Publicado: (2023)

Proliferation of the Superficial Epithelium of Ovaries in Senile Female Rats Following Oral Administration of Conjugated Equine Estrogens
por: Perniconi, Sergio Eduardo, et al.
Publicado: (2008)

Equilin in conjugated equine estrogen increases monocyte-endothelial adhesion via NF-κB signaling
por: Ito, Fumitake, et al.
Publicado: (2019)

SUN-LB003 The Steroid Sulfatase Dictates the Hormone Replacement Therapy Efficacy of the Conjugated Equine Estrogen
por: Feng, Ye, et al.
Publicado: (2019)

Impact of 6 month conjugated equine estrogen versus estradiol-treatment on biomarkers and enriched gene sets in healthy mammary tissue of non-human primates
por: Hobi, Gabriel, et al.
Publicado: (2022)

The Effect of Letrozole Combined with Dydrogesterone for Endometriosis in China: A Meta-Analysis
por: Sun, Shumei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cmm62dh46h5q9360rdab0ouob6